Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Gv 2019, L.P. investment portfolio
Gv 2019, L.P. has made numerous investments in companies such as Biomodal, Multiverse Group, and Nplan within the Healthcare & Life Sciences sector.
unknown
Portfolio
5
Team
0
Portfolio (5)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Biomodal Limited Biomodal develops omics‑based life‑science technology and analytics products that provide single‑base‑resolution sequencing and multi‑omics solutions, extracting detailed genetic and epigenetic information from low‑input DNA samples. Its offerings serve researchers and developers working on cancer, neurodegenerative disease and ageing. | Healthcare & Life Sciences | Saffron Walden | Confirmed | 2025-03-26 |
| Evox Therapeutics Limited Evox Therapeutics develops exosome‑based gene‑editing medicines that use a proprietary CRISPR editor delivered via extracellular vesicles to create safer, scalable treatments for severe neurodegenerative diseases, targeting patients with brain‑related genetic disorders. | Healthcare & Life Sciences | Oxford | Confirmed | 2026-03-16 |
Shareholding changes (2)
Sign up free to see when this investor has bought or sold shares.
Sign up free